The importance of the detection of anti-P30 IgA antibodies in acquired toxoplasmosis

• Autorzy: Paul M , Goullier-Fleuret A , Pelloux H , Ambroise-Thomas P
• Języki publikacji: EN

Abstrakty

EN

The study was undertaken to find out whether the detection of the IgA antibodies against T. gondii is a better serological marker of the acute phase of toxoplasmosis than the detection of IgM. Eighty four serum samples from 70 patients with acquired toxoplasmosis were tested. The duration of the T. gondii invasion was from one week to over one year. IgA antibodies against P30 (SAG1), a major surface protein of T. gondii, were tested using CLONATEC TOXO A Ab EIA assay. Among 84 sera, the specific IgM antibodies were found in 82 cases (97.6%) but the IgA antibodies were detected in 42 cases (50%), which suggest that they are more time specific. The IgA antibodies start to appear in the sera between 2-4 weeks after invasion, i.e. later than those of IgM, and concomitantly or shortly after IgG. In 65% of cases of very recent infections (less than 4 weeks) IgA antibodies were not detected. The highest values for IgA were found in samples collected 2-3 months after invasion and disappeared between 5-9 months. IgA antibodies were frequently found in patients with high IgG antibody titers (91%), but were not detected when IgG titers were decreasing. There were no IgA antibodies present in the patients one year after invasion, however, in some patients the IgM antibodies were still present (“residual” IgM antibodies). Detection of the IgA specific antibodies is a valuable marker of the acute phase of toxoplasmosis between 4 weeks and 4 months, however, their presence has to be interpreted together with other serological tests examining IgG and IgM.

Słowa kluczowe

EN

parasite; toxoplasmosis; serological test; infection; patient; Toxoplasma gondii; detection; antibody

• Wydawca: -
• Czasopismo: Acta Parasitologica
• Rocznik: 1996
• Tom: 41
• Numer: 4
• Opis fizyczny: p.227-233,fig.

Twórcy

autor

Paul M

• Clinic of Parasitic and Tropical Diseases, Karol Marcinkowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland

autor

Goullier-Fleuret A

• Department de Parasitologie-Mycologie Medicale et Moleculaire, Centre Hospitalier Universitaire de Grenoble, BP 217, 38043 Grenoble Cedex 9, France

autor

Pelloux H

• Department de Parasitologie-Mycologie Medicale et Moleculaire, Centre Hospitalier Universitaire de Grenoble, BP 217, 38043 Grenoble Cedex 9, France

autor

Ambroise-Thomas P

• Department de Parasitologie-Mycologie Medicale et Moleculaire, Centre Hospitalier Universitaire de Grenoble, BP 217, 38043 Grenoble Cedex 9, France

Bibliografia

• Bessières M. H., Roques C., Berrebi A., Barre V., Cazaux M., Séguéla J. P. 1992. IgA antibody response during acquired and congenital toxoplasmosis. Journal of Clinical Pathology, 45, 605-608.
• Cazenave J., Bessières M. H. 1992. Le diagnostic anténatal de la toxoplasmose. Revue Française des Laboratoires, 240, 95- 102.
• Chumpitazi B. F. F., Boussaid A., Pelloux H., Racinet C., Bost M., Goullier-Fleuret A. 1995. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. Journal of Clinical Microbiology, 33, 1479-1485.
• Decoster A., Caron A., Darcy F., Capron A. 1988. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet, 12, 1104-1106.
• Decoster A., Darcy F., Caron A., Vinatier D., Houze de l’Aulnoit D., Vittu G., Niel G., Heyer R., Lecolier B., Delcroix M., Monnier J.C., Duhamel M., Capron A. 1992. Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection. Clinical Experimental Immunology, 87, 310-315.
• Favre G., Bessières M. H., Seguela J. P. 1984. Dosage des IgA sériques spécifiques de la toxoplasmose par une méthode ELISA. Application à 120 cas. Bulletin de la Société Française de Parasitologie, 3, 139-142.
• Hohlfeld P., Forestier F., Marion S., Thulliez P., Marcon P., Daffos F. 1990. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses. Pediatric Infectious Disease Journal, 9, 878-881.
• Jacquier P., Zufferey J., Wunderli W. 1995. Diagnostic biologique de la toxoplasmose au cours de la grossesse: méthodes, interprétations et recommandations pratiques. Schweizerische Medizinische Wochenschrift, 125 (Suppl. 65), 39S-51S.
• Lappalainen M., Koskela P., Koskiniemi M., Teramo K., Raivio K. O., Remington J. S., Hedman K. 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. Journal of Infectious Diseases, 167, 691-697.
• Lecolier B., Pucheu B. 1993. Intérêt de l’étude de l’avidité des IgG pour le diagnostic de la toxoplasmose. Pathologie Biologie, 41, 155-158.
• Le Fichoux Y., Marty P., Chan H. 1987. Les IgA sériques spécifiques dans le diagnostic de la toxoplasmose. Annales de Pédiatrie, 34, 375-379.
• Le Fichoux Y., Marty P., Chan H., Doucet J. 1984. Détection des IgM anti-toxoplasmiques par I.S.Ag.A. A propos de 3786 sérologies. Bulletin de la Société Française de Parasitologie, 3, 13-18.
• Mack D. G., McLeod R. 1992. Human Toxoplasma gondii- specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro. Journal of Clinical Investigation, 90, 2585-2592.
• Marty P., Le Fichoux Y. 1992. Couplage des 2 tests TOXO G EIA/IMX TOXO IgG pour la datation d’une contamination toxoplasmique chez la femme enceinte. Bulletin de la Société Française de Parasitologie, 10, 177-182.
• McLeod R., Mack D. G. 1986. Secretory IgA specific for Toxoplasma gondii. Journal of Immunology, 136, 2640-2643.
• Partanen P., Turunen H. J., Paasivuo R. T. A., Leinikki P. D. 1984. Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulin G, M and A antibodies at different stages of infection. Journal of Clinical Microbiology, 20, 133-135.
• Patel B., Young Y., Duffy K., Tanner R. P., Johnson J., Holliman R. E. 1993. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis. Journal of Medical Microbiology, 38, 286-292.
• Pelloux H., Ciapa P., Goullier-Fleuret A., Ambroise-Thomas P. 1993. Evaluation du système Vidas pour le diagnostic sérologique de la toxoplasmose. Annales de Biologie Clinique, 50, 875-878.
• Pinon J. M., Gruson N. 1982. Intérêt des profils immunologiques comparés ELIFA dans le diagnostic précose de la toxoplasmose congénitale. Lyon Médical, 248, 27-30.
• Stepick-Biek P., Thulliez P., Araujo F. G., Remington J. S. 1990. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. Journal of Infectious Diseases, 162, 270- 273.
• Van Loon A. M., Van der Logt J. T. M., Heessen F. W. A., Van der Veen J. 1983. Enzyme-linked immunosorbent assay that uses labeled antigen for detection of IgM and IgA antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double sandwich enzyme-linked immunosorbent assay. Journal of Clinical Microbiology, 17, 997-1004.
• Wong S. Y., Hajdu M. P., Ramirez R., Thulliez P., McLeod R., Remington J. S. 1993. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. Journal of Clinical Microbiology, 31, 2952-2959.